House Oversight Committee Investigates DEA Fentanyl Interdiction Tactics

House Oversight Committee Chairman James Comer launched an investigation into the Drug Enforcement Administration (DEA) over a policing tactic that allowed large shipments of fentanyl to reach the streets to facilitate larger criminal cases. In a letter to Attorney General Todd Blanche, Comer requested records regarding the alleged relaxation of risk mitigation protocols established in 2017 and 2019. He described the practice of allowing drugs to "walk" as "unconscionable," claiming it led to a 21 percent increase in fentanyl poisoning deaths in New Mexico while national overdose deaths decreased by 14 percent.

The inquiry follows a lawsuit by New Mexico Attorney General Raúl Torrez and reports from whistleblowers who claim agents in New Mexico monitored shipments of up to 100,000 pills without intervening between 2023 and 2025. Reports indicate that while Comer focused on the Biden administration, the practice continued into Donald Trump's second administration. In Albuquerque, agents reportedly watched couriers enter hotels with backpacks of fentanyl without taking action.

DEA Administrator Terry Cole defended the agency's long-term investigative methods, stating they are conducted under the guidance of the law. Meanwhile, the United States Department of Justice internal watchdog has announced a nationwide review of these policies to determine their impact and legality.